Which hedge funds own PLRX? PLIANT THERAPEUTICS INC, Q2 2026 13F holders

26 tracked hedge funds disclosed a position in PLRX (PLIANT THERAPEUTICS INC) in their Q2 2026 13F filings, worth $28.0m in total. The largest holder by portfolio weight is BML Capital Management, LLC at 1.0% of its book. 4 opened a new position this quarter: Lynx1 Capital Management LP, Ikarian Capital, LLC, Spark Investment Management LLC, Boothbay Fund Management, LLC. 2 exited: Centiva Capital, LP, Bronte Capital Management Pty Ltd..

26

Holders

Tracked managers whose filing for the quarter reports a long equity position in the security.

4

New this quarter

Holders whose previous filing (at most two quarters earlier) did not report the security.

2

Exited this quarter

Tracked managers whose previous filing reported the security and whose filing for the quarter does not.

$3.6m

Inflow, new holders

Combined value of the positions the new holders reported for the quarter.

$568k

Outflow, exits

Combined value the exiting managers reported for the security in their previous filing.

$28.0m

Combined value

Sum of the holders' reported positions in the security.

2.1%

Share of managers holding

Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.